BFNH Stock Overview
BioForce Nanosciences Holdings, Inc. focuses on providing natural vitamins, minerals, other nutritional supplements, powders, and beverages for individuals in various age ranges.
Snowflake Score | |
---|---|
Valuation | 0/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 0/6 |
Dividends | 0/6 |
BioForce Nanosciences Holdings, Inc. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | US$1.63 |
52 Week High | US$2.75 |
52 Week Low | US$1.10 |
Beta | -2.11 |
1 Month Change | -4.12% |
3 Month Change | -12.83% |
1 Year Change | 12.41% |
3 Year Change | 10.88% |
5 Year Change | -71.65% |
Change since IPO | 226.00% |
Recent News & Updates
Recent updates
Shareholder Returns
BFNH | US Personal Products | US Market | |
---|---|---|---|
7D | -6.3% | -0.5% | 1.0% |
1Y | 12.4% | -28.8% | 21.9% |
Return vs Industry: BFNH exceeded the US Personal Products industry which returned -26% over the past year.
Return vs Market: BFNH underperformed the US Market which returned 24.9% over the past year.
Price Volatility
BFNH volatility | |
---|---|
BFNH Average Weekly Movement | 22.3% |
Personal Products Industry Average Movement | 8.8% |
Market Average Movement | 6.0% |
10% most volatile stocks in US Market | 16.8% |
10% least volatile stocks in US Market | 3.0% |
Stable Share Price: BFNH's share price has been volatile over the past 3 months.
Volatility Over Time: BFNH's weekly volatility has increased from 17% to 22% over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1999 | 3 | Steve Gagnon | www.bioforceeclipse.com |
BioForce Nanosciences Holdings, Inc. focuses on providing natural vitamins, minerals, other nutritional supplements, powders, and beverages for individuals in various age ranges. The company offers private label products with distributors and manufacturing providers. It sells its nutrition supplements to retailers, sporting goods retailers, supermarkets, mass merchandisers, and online under the BioForce Eclipse brand, as well as through social media and telemarketing.
BioForce Nanosciences Holdings, Inc. Fundamentals Summary
BFNH fundamental statistics | |
---|---|
Market cap | US$47.71m |
Earnings (TTM) | -US$471.95k |
Revenue (TTM) | n/a |
0.0x
P/S Ratio-101.1x
P/E RatioIs BFNH overvalued?
See Fair Value and valuation analysisEarnings & Revenue
BFNH income statement (TTM) | |
---|---|
Revenue | US$0 |
Cost of Revenue | US$0 |
Gross Profit | US$0 |
Other Expenses | US$471.95k |
Earnings | -US$471.95k |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
Earnings per share (EPS) | -0.016 |
Gross Margin | 0.00% |
Net Profit Margin | 0.00% |
Debt/Equity Ratio | -12.1% |
How did BFNH perform over the long term?
See historical performance and comparison